Novel targeted therapies have become standard treatment for chronic lymphocytic leukemia due to their ability to delay progression of this slow-growing malignancy. Nevertheless, CLL remains incurable.

The patient "seems to have made a full recovery" after the brain-science company implanted the quarter-size chip in January, Musk said on Monday Nathan Laine/Bloomberg via Getty Neuralink founder Elon ...

Mary Maloney isn’t about to let paralysis stop her from moving forward. Maloney, 16, suffered a series of accidents — a spinal cord stroke in 2020, then a broken leg after a car crash this year. Her ...

There's help for providers who want to help aging patients navigate complex government websites and access the information and resources they need to overcome isolation, lack of transportation and ...

Imagine losing your ability to speak or move, yet still having so much to say. For Brad G. Smith, this became his reality after being diagnosed with ALS, a rare and progressive disease that attacks ...

Neuralink owner Elon Musk says the company's first human patient is now able to control basic computer mouse movements using a brain implant they received earlier this year. In a discussion on X ...